New radiofrequency device aims to smooth acne scars

NCT ID NCT07620769

Not yet recruiting Symptom relief Sponsor: CLASSYS Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a radiofrequency device to treat atrophic acne scars—the pitted kind left after acne. About 252 people aged 18 to 65 with facial scars will receive either the active device or a control. Researchers will check scar improvement 12 weeks after treatment using a standard scar scale.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiofrequency therapeutic device
What this could lead to: If successful, this could offer a new, non-invasive option to reduce the appearance of acne scars.
What could go wrong: This is an early-stage trial with no phase designation, so results are uncertain. The device may not work better than existing treatments, and side effects like pain or skin reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE SCAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE SCAR ACNE SCARRING ACNE SCARS ACNE SCARS - ATROPHIC

Contacts and locations

Locations

Huashan Hospital Affiliated to Fudan University

Shanghai, China
The Chengdu Second People's Hospital

Chengdu, China
The First Affiliated Hospital of Chongqing Medical University

Chongqing, China
The First Hospital of Hebei Medical University

Hebei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.